Prostatype Genomics AB Logo

Prostatype Genomics AB

Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.

PROGEN | ST

Overview

Corporate Details

ISIN(s):
SE0022574554 (+2 more)
LEI:
549300JO6MPCGPVHVU91
Country:
Sweden
Address:
Gustav III:s Boulevard 34, 169 73 Solna
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test, Prostatype®. The test is designed to provide a comprehensive assessment of the aggressiveness of diagnosed prostate cancer, particularly for patients with localized disease. It serves as a decision-making tool for clinicians and patients to help determine appropriate treatment strategies. The Prostatype® system uses existing biopsy tissue to analyze the expression of three key genes. This genetic data is combined with standard clinical parameters (PSA, Gleason Score, Tumor Stage) to calculate a proprietary P-score, which quantifies the risk of cancer mortality. By offering a more precise prognosis, the test aims to minimize both over- and under-treatment, thereby improving patient quality of life and saving healthcare resources.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Prostatype Genomics AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prostatype Genomics AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops & manufactures medical devices, implants, and surgical instruments for global healthcare.
South Korea 043100
Alteco Medical AB Logo
Develops blood purification devices to treat sepsis and septic shock in ICUs.
Sweden ALTE
Ambu Logo
Develops single-use devices for endoscopy, anesthesia, and patient monitoring to improve safety.
Denmark AMBU
Amplitude Surgical Logo
Develops and markets high-end orthopedic implants for hip and knee pathologies worldwide.
France AMPLI
Develops robotic exoskeletons for rehabilitation and mobility assistance.
South Korea 455900
ANGLE PLC Logo
Offers a liquid biopsy system to harvest circulating tumor cells for oncology diagnostics & research.
United Kingdom AGL
anymedi Inc. Logo
AI-powered 3D printed surgical guides & implants for medical and cosmetic surgery.
South Korea 390110
Provides at-home topical oxygen therapy for chronic wounds, reducing amputations and costs.
United States of America N/A
Arjo Logo
Medical devices and solutions for mobility challenges in healthcare facilities.
Sweden ARJO
ASAHI  INTECC CO.,LTD. Logo
Manufacturer of fine-wire guidewires & catheters for global minimally invasive procedures.
Japan 7747

Talk to a Data Expert

Have a question? We'll get back to you promptly.